Mergers & acquisitions

Mar 21, 2013

Moderna Therapeutics, a Cambridge, Mass.-based developer of a biotherapeutic platform that can stimulate the body's natural ability to produce therapeutic proteins, has signed a strategic partnership with AstraZeneca (LSE: AZN) to developer and commercialize treatments for cardiovascular, metabolic, renal and oncological diseases. The deal includes a $240 million up-front cash payment, plus $180 million in technical milestone-based earnouts. Moderna recently raised more than $40 million in VC funding led by Flagship Ventures.

Pinterest has acquired mobile recommendation engine Livestar, with plans to shut down the startup’s service. No financial terms were disclosed. Pinterest shareholders include Andreessen Horowitz, Bessemer Venture Partners, FirstMark Capital, Rakuten and Valiant Capital Management.

Vivendi SA is considering spinning off its SFR telecom unit, which made up 40% of 2012 revenue, according to Bloomberg.

Sign up for my daily email newsletter on deals and deal-makers:

All products and services featured are based solely on editorial selection. FORTUNE may receive compensation for some links to products and services on this website.

Quotes delayed at least 15 minutes. Market data provided by Interactive Data. ETF and Mutual Fund data provided by Morningstar, Inc. Dow Jones Terms & Conditions: S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions